Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Konopka-Anstadt JL"'
Autor:
Snider CJ; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Zaman K; icddr,b, 68 Shahid Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh., Wilkinson AL; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA. Electronic address: lxq6@cdc.gov., Binte Aziz A; icddr,b, 68 Shahid Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh., Yunus M; icddr,b, 68 Shahid Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh., Haque W; icddr,b, 68 Shahid Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh., Jones KAV; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Wei L; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Estivariz CF; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Konopka-Anstadt JL; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Mainou BA; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Patel JC; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Lickness JS; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Pallansch MA; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Wassilak SGF; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Steven Oberste M; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA., Anand A; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Atlanta, GA 30329, USA.
Publikováno v:
Vaccine [Vaccine] 2023 Sep 22; Vol. 41 (41), pp. 6083-6092. Date of Electronic Publication: 2023 Aug 29.
Autor:
Wilkinson AL; US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lxq6@cdc.gov., Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Hoque M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Estivariz CF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Mainou BA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Kovacs SD; US Centers for Disease Control and Prevention, Atlanta, GA, USA., An Q; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Lickness JS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Yunus M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Snider CJ; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Zhang Y; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Coffee E; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Abid T; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Wassilak SGF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Pallansch MA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Vertefeuille JF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Anand A; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Sep; Vol. 23 (9), pp. 1062-1071. Date of Electronic Publication: 2023 May 10.
Autor:
Yeh MT; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA., Smith M; National Institute for Biological Standards and Control, South Mimms, UK., Carlyle S; National Institute for Biological Standards and Control, South Mimms, UK., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Burns CC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Konz J; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Andino R; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA. Raul.Andino@ucsf.edu., Macadam A; National Institute for Biological Standards and Control, South Mimms, UK. Andrew.Macadam@nibsc.org.
Publikováno v:
Nature [Nature] 2023 Jul; Vol. 619 (7968), pp. 135-142. Date of Electronic Publication: 2023 Jun 14.
Autor:
Erdem R; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., De Coster I; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Edegem, Belgium. Electronic address: ilse.decoster@uantwerpen.be., Withanage K; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Edegem, Belgium., Mercer LD; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Marchant A; Institute for Medical Immunology, Université libre de Bruxelles, Brussels, Belgium., Taton M; Institute for Medical Immunology, Université libre de Bruxelles, Brussels, Belgium., Cools N; Vaccine & Infectious Disease Institute, Laboratory of Experimental Hematology, University of Antwerp, Wilrijk, Belgium., Lion E; Vaccine & Infectious Disease Institute, Laboratory of Experimental Hematology, University of Antwerp, Wilrijk, Belgium., Cassels F; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Higgins D; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Ivinson K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Locke E; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Mahmood K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Wright PF; Dartmouth College, Lebanon, NH, USA., Gast C; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., White JA; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Ackerman ME; Dartmouth College, Lebanon, NH, USA., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mainou BA; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Van Damme P; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Edegem, Belgium.
Publikováno v:
Vaccine [Vaccine] 2023 Mar 03; Vol. 41 (10), pp. 1657-1667. Date of Electronic Publication: 2023 Feb 04.
Autor:
Zaman K; International Centre for Diarrhoeal Disease Research, Chandpur, Bangladesh., Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, WA, USA. Electronic address: ananda.bandyopadhyay@gatesfoundation.org., Hoque M; International Centre for Diarrhoeal Disease Research, Chandpur, Bangladesh., Gast C; PATH, Seattle, WA, USA., Yunus M; International Centre for Diarrhoeal Disease Research, Chandpur, Bangladesh., Jamil KM; National Polio and Measles Laboratory, Institute of Public Health, Dhaka, Bangladesh., Mainou BA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; PATH, Seattle, WA, USA., Hendley WS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Vincent A; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Clemens R; Global Research in Infectious Diseases, Rio de Janeiro, Brazil., Clemens SAC; Global Research in Infectious Diseases, Rio de Janeiro, Brazil; Department of Paediatrics, Oxford University, Oxford, UK., Ross AG; International Centre for Diarrhoeal Disease Research, Chandpur, Bangladesh; Rural Health Research Institute, Charles Sturt University, Wagga Wagga, NSW, Australia., Clemens JD; International Centre for Diarrhoeal Disease Research, Chandpur, Bangladesh; International Vaccine Institute, Seoul, South Korea., Tritama E; PT Bio Farma, Bandung, Indonesia.
Publikováno v:
Lancet (London, England) [Lancet] 2023 Jan 14; Vol. 401 (10371), pp. 131-139. Date of Electronic Publication: 2022 Dec 07.
Autor:
Wahid R; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Mercer LD; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., De Leon T; Hospital Materno Infantil José Domingo De Obaldía, David, Panama; CEVAXIN, Centro de Vacunación e Investigación, Panama City, Panama., DeAntonio R; CEVAXIN, Centro de Vacunación e Investigación, Panama City, Panama., Sáez-Llorens X; CEVAXIN, Centro de Vacunación e Investigación, Panama City, Panama; Department of Infectious Diseases, Hospital del Niño Dr José Renán Esquivel and Sistema Nacional de Investigación at Secretaria Nacional de Ciencia y Tecnologia, Panama City, Panama., Macadam A; Division of Virology, National Institute for Biological Standards and Control, South Mimms, UK., Chumakov K; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Global Virus Network Center of Excellence, Baltimore, MD, USA., Strating J; Viroclinics Biosciences, Rotterdam, Netherlands., Koel B; Viroclinics Xplore, Viroclinics Biosciences, Rotterdam, Netherlands., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Andino R; Department of Microbiology and Immunology, University of California, San Francisco, CA, USA., Tritama E; Research and Development Division, PT Bio Farma, Bandung, West Java, Indonesia., Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, WA, USA., Aguirre G; Fighting Infectious Diseases in Emerging Countries, Miami, FL, USA., Rüttimann R; Fighting Infectious Diseases in Emerging Countries, Miami, FL, USA., Gast C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Konz JO; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA. Electronic address: jkonz@path.org.
Publikováno v:
The Lancet. Microbe [Lancet Microbe] 2022 Dec; Vol. 3 (12), pp. e912-e921. Date of Electronic Publication: 2022 Nov 01.
Autor:
Rhoden EE; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: erhoden@cdc.gov., Mainou BA; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Publikováno v:
Journal of virological methods [J Virol Methods] 2022 Oct; Vol. 308, pp. 114590. Date of Electronic Publication: 2022 Jul 22.
Autor:
Gast C; PATH, Seattle, Washington, USA., Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, Washington, USA., Sáez-Llorens X; Infectious Disease Department, Hospital del Niño 'Dr José Renán Esquivel,' Panama City, Panama.; Sistema Nacional de Investigación, Senacyt, Panama., De Leon T; Cevaxin, Panama City, Panama., DeAntonio R; Cevaxin, Panama City, Panama., Jimeno J; VaxTrials, Panama City, Panama., Aguirre G; Fighting Infectious Diseases in Emerging Countries, Miami, Florida, USA., McDuffie LM; Cherokee Nation Assurance, contracting agency to the Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Coffee E; Cherokee Nation Assurance, contracting agency to the Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mathis DL; Cherokee Nation Assurance, contracting agency to the Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Oberste MS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Weldon WC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Modlin J; Bill & Melinda Gates Foundation, Seattle, Washington, USA., Bachtiar NS; PT Bio Farma, Bandung, Indonesia., Fix A; PATH, Seattle, Washington, USA., Konz J; PATH, Seattle, Washington, USA., Clemens R; Global Research in Infectious Diseases, Rio de Janeiro, Brazil., Costa Clemens SA; Institute for Global Health, University of Siena, Siena, Italy., Rüttimann R; Fighting Infectious Diseases in Emerging Countries, Miami, Florida, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Sep 13; Vol. 226 (5), pp. 852-861.
Autor:
Aravamudhan P; Department of Pediatrics, University of Pittsburgh School of Medicinegrid.471408.e, Pittsburgh, Pennsylvania, USA.; Institute of Infection, Inflammation, and Immunity, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Guzman-Cardozo C; Department of Pediatrics, University of Pittsburgh School of Medicinegrid.471408.e, Pittsburgh, Pennsylvania, USA.; Institute of Infection, Inflammation, and Immunity, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Urbanek K; Department of Pediatrics, University of Pittsburgh School of Medicinegrid.471408.e, Pittsburgh, Pennsylvania, USA.; Institute of Infection, Inflammation, and Immunity, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Welsh OL; Department of Pediatrics, University of Pittsburgh School of Medicinegrid.471408.e, Pittsburgh, Pennsylvania, USA.; Institute of Infection, Inflammation, and Immunity, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Konopka-Anstadt JL; Department of Pediatrics, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA., Sutherland DM; Department of Pediatrics, University of Pittsburgh School of Medicinegrid.471408.e, Pittsburgh, Pennsylvania, USA.; Institute of Infection, Inflammation, and Immunity, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Dermody TS; Department of Pediatrics, University of Pittsburgh School of Medicinegrid.471408.e, Pittsburgh, Pennsylvania, USA.; Institute of Infection, Inflammation, and Immunity, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicinegrid.471408.e, Pittsburgh, Pennsylvania, USA.
Publikováno v:
Journal of virology [J Virol] 2022 Apr 27; Vol. 96 (8), pp. e0005522. Date of Electronic Publication: 2022 Mar 30.
Autor:
Wahid R; PATH, Seattle, WA, USA. rwahid@path.org., Mercer L; PATH, Seattle, WA, USA., Gast C; PATH, Seattle, WA, USA., De Leon T; Hospital Materno Infantil José Domingo De Obaldía, David, Panama.; Centro de Investigación en Vacunas (Cevaxin), Panama City, Panama., Sáez-Llorens X; Centro de Investigación en Vacunas (Cevaxin), Panama City, Panama.; Department of Infectious Diseases at Hospital del Niño Dr. José Renán Esquivel, Sistema Nacional de Investigación at Secretaria Nacional de Ciencia y Tecnologia (SENACYT), Panama City, Panama., Fix A; PATH, Seattle, WA, USA., Macadam A; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Stephens L; National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK., Chumakov K; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.; Global Virus Network Center of Excellence, Baltimore, MD, USA., Smits SL; Viroclinics Biosciences B.V, Rotterdam, the Netherlands., Murreddu M; Viroclinics Xplore, Viroclinics Biosciences B.V, Rotterdam, the Netherlands., Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Steven Oberste M; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Andino R; Department of Microbiology and Immunology, University of California, San Francisco, CA, USA., Bachtiar NS; Research and Development Division, PT. Bio Farma, Bandung, West Java, Indonesia., Tritama E; Research and Development Division, PT. Bio Farma, Bandung, West Java, Indonesia., Bandyopadhyay AS; Bill and Melinda Gates Foundation, Seattle, WA, USA., Aguirre G; Fighting Infectious Diseases in Emerging Countries (FIDEC), Miami, FL, USA., Rüttimann R; Fighting Infectious Diseases in Emerging Countries (FIDEC), Miami, FL, USA., Konz JO; PATH, Seattle, WA, USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2022 Feb 11; Vol. 7 (1), pp. 19. Date of Electronic Publication: 2022 Feb 11.